Skip to main content
. 2015 Sep 15;138(11):3373–3385. doi: 10.1093/brain/awv267

Figure 4.

Figure 4

CSF neurogranin in relation to cognition and future cognitive change. MMSE and ADAS-Cog at baseline (A and B) and over time (C and D) as a function of baseline CSF neurogranin (Ng) in different diagnostic groups. Shaded areas indicate 95% confidence interval (CI) of the mean. CN = cognitively normal (green); sMCI = stable MCI (red); pMCI = progressive MCI (blue); AD = Alzheimer’s disease (grey).